Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

This study has been completed.

Study NCT00036257 Information provided by OSI Pharmaceuticals

First Received: May 8, 2002 Last Updated: April 3, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2003
Estimated Primary Completion Date:	No date given